HCA

SEC source: 0000950170-25-067306 · ownership.xml · nonDerivative · entry 7

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By MAM 2020 Trust

Disclosed balance after: 43,120

SEC source: 0000950170-25-067306 · ownership.xml · nonDerivative · entry 6

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By ML Trust

Disclosed balance after: 285

SEC source: 0000950170-25-067306 · ownership.xml · nonDerivative · entry 5

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144

SEC source: 0000950170-25-067306 · ownership.xml · nonDerivative · entry 4

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288

F1 · kind: Pursuant to a power of substitution, on May 6, 2025, the Reporting Person transferred 288 shares of common stock of the Issuer from a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $353.575 (the average of the high and low prices of shares of common stock of the Issuer on May 6, 2025). The transfer resulted in a decrease in the number of shares the Reporting Person beneficially owns indirectly through the trust and a corresponding increase in the number of shares the Reporting Person beneficially owns directly, but therefore did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares from the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.

SEC source: 0000950170-25-067306 · ownership.xml · nonDerivative · entry 3

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By MAM 2020 Trust

Disclosed balance after: 42,939

F1 · kind: Pursuant to a power of substitution, on May 6, 2025, the Reporting Person transferred 288 shares of common stock of the Issuer from a trust account in exchange for assets of equal value. The transfer was made at a price per share equal to $353.575 (the average of the high and low prices of shares of common stock of the Issuer on May 6, 2025). The transfer resulted in a decrease in the number of shares the Reporting Person beneficially owns indirectly through the trust and a corresponding increase in the number of shares the Reporting Person beneficially owns directly, but therefore did not change the total number of shares of common stock of the Issuer of which the Reporting Person may be deemed to have beneficial ownership. The Reporting Person believes that the transfer of shares from the trust constitutes a change in form of beneficial ownership of such shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.

SEC source: 0000950170-25-067306 · ownership.xml · nonDerivative · entry 2

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Indirect · By ML Trust

Disclosed balance after: 466

SEC source: 0000950170-25-067306 · ownership.xml · nonDerivative · entry 1

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

SEC source: 0001140361-25-016965 · form4.xml · nonDerivative · entry 2

Frist William R · CIK 0001433377 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · Held indirectly by WRF 2015, LLC

Disclosed balance after: 1,574,896.8051

F2 · ownership.nature: Hercules Holding II ("Hercules") holds 68,912,077 shares of common stock of HCA Healthcare, Inc. Hercules is held by a private investor group, including affiliates of HCA Inc. founder Dr. Thomas F. Frist Jr. The Reporting Person may be deemed to be a member of a group exercising voting and investment control over the shares of common stock of HCA Healthcare, Inc. held by Hercules. However, the Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein.

F3 · ownership.nature: The Reporting Person is an officer and a managing member of WRF 2015, LLC and may be deemed to own indirectly the 1,562,273.8051 units of Hercules and the 12,623 shares of common stock of HCA Healthcare, Inc. held by such entity, and may therefore be deemed to own indirectly the same number of shares of common stock of HCA Healthcare, Inc.

F4 · ownership.nature: On April 30, 2025, the Reporting Person and the William R. Frist 2010 Family Trust transferred units of WRF 2015, LLC to a trust for the benefit of the Reporting Person's children, of which the Reporting Person's spouse is a trustee. The units transferred corresponded to indirect ownership of a total of 10,420.3663 units of Hercules and 84.1954 shares of common stock of HCA Healthcare, Inc. and were made at a net cash price of $340.60 (the average of the high and low prices of the shares of common stock of HCA Healthcare, Inc. on April 30, 2025) per share of common stock of HCA Healthcare, Inc. or unit of Hercules. In each case, these transfers changed neither the number of units of Hercules or shares of common stock of HCA Healthcare, Inc. held by WRF 2015, LLC, nor the total number of shares of common stock of HCA Healthcare, Inc. of which the Reporting Person may be deemed to have beneficial ownership.

SEC source: 0001140361-25-016961 · form4.xml · nonDerivative · entry 1

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,817

F1 · kind: Represents common stock of HCA Healthcare, Inc. underlying 645 restricted share units attributable to an annual director equity award and 675 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2026 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001140361-25-016965 · form4.xml · nonDerivative · entry 1

Frist William R · CIK 0001433377 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,931

F1 · kind: Represents common stock of HCA Healthcare, Inc. underlying 645 restricted share units attributable to an annual director equity award and 381 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2026 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0000950170-25-062141 · ownership.xml · nonDerivative · entry 1

Smith Andrea B · CIK 0001649634 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,157

F1 · kind: Represents common stock underlying 645 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0000950170-25-062139 · ownership.xml · nonDerivative · entry 1

Riley Wayne Joseph · CIK 0001432895 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,520

F1 · kind: Represents common stock underlying 645 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0000950170-25-062126 · ownership.xml · nonDerivative · entry 1

Johnston Hugh F · CIK 0001377489 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,666

F1 · kind: Represents common stock underlying 645 restricted share units attributable to an annual director equity award and 381 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2026 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0000950170-25-062136 · ownership.xml · nonDerivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,651

F1 · kind: Represents common stock underlying 645 restricted share units attributable to an annual director equity award and 528 restricted share units received in lieu of annual cash retainers for service as a director and as independent presiding director. The restricted share units shall vest on the sooner of the date of the 2026 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0000950170-25-062112 · ownership.xml · nonDerivative · entry 1

Dennis Robert J · CIK 0001295441 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,601

F1 · kind: Represents common stock underlying 645 restricted share units attributable to an annual director equity award and 381 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2026 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0000950170-25-062120 · ownership.xml · nonDerivative · entry 1

DEPARLE NANCY ANN · CIK 0001144511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,401

F1 · kind: Represents common stock underlying 645 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0000950170-25-022648 · ownership.xml · nonDerivative · entry 4

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,412

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $321.70 to $322.69, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-25-022648 · ownership.xml · nonDerivative · entry 3

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,790

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $322.71 to $323.28, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0000950170-25-022667 · ownership.xml · nonDerivative · entry 2

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,067

SEC source: 0000950170-25-022667 · ownership.xml · nonDerivative · entry 1

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,294

F1 · kind: On January 28, 2022, the reporting person was granted 1,630 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

SEC source: 0000950170-25-022666 · ownership.xml · nonDerivative · entry 2

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,113

SEC source: 0000950170-25-022666 · ownership.xml · nonDerivative · entry 1

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,340

F1 · kind: On January 28, 2022, the reporting person was granted 1,630 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

SEC source: 0000950170-25-022664 · ownership.xml · nonDerivative · entry 2

McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,696

SEC source: 0000950170-25-022664 · ownership.xml · nonDerivative · entry 1

McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,227

F1 · kind: On January 28, 2022, the reporting person was granted 4,080 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

SEC source: 0000950170-25-022663 · ownership.xml · nonDerivative · entry 2

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 466

SEC source: 0000950170-25-022663 · ownership.xml · nonDerivative · entry 1

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 638

F1 · kind: On January 28, 2022, the reporting person was granted 1,230 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

SEC source: 0000950170-25-022661 · ownership.xml · nonDerivative · entry 2

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,344

SEC source: 0000950170-25-022661 · ownership.xml · nonDerivative · entry 1

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,028

F1 · kind: On January 28, 2022, the reporting person was granted 5,300 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

SEC source: 0000950170-25-022662 · ownership.xml · nonDerivative · entry 2

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,676

SEC source: 0000950170-25-022662 · ownership.xml · nonDerivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,418

F1 · kind: On January 28, 2022, the reporting person was granted 25,470 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

SEC source: 0000950170-25-022652 · ownership.xml · nonDerivative · entry 2

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,425.2085

SEC source: 0000950170-25-022652 · ownership.xml · nonDerivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,008.2085

F1 · kind: On January 28, 2022, the reporting person was granted 4,490 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

SEC source: 0000950170-25-022648 · ownership.xml · nonDerivative · entry 2

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,945

SEC source: 0000950170-25-022648 · ownership.xml · nonDerivative · entry 1

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,352

F1 · kind: On January 28, 2022, the reporting person was granted 3,060 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2022-2024. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2022-2024 earnings per share, the number of performance share units that vested equaled 51.9% of the units granted.

SEC source: 0000950170-25-018161 · ownership.xml · derivative · entry 5

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,340 shares

Expires 2029-01-30

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.

SEC source: 0000950170-25-018161 · ownership.xml · derivative · entry 4

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,440 shares

Expires 2028-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.

SEC source: 0000950170-25-018161 · ownership.xml · nonDerivative · entry 3

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,764

SEC source: 0000950170-25-018161 · ownership.xml · nonDerivative · entry 2

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,511

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-25-018161 · ownership.xml · nonDerivative · entry 1

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,171

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0000950170-25-014816 · ownership.xml · derivative · entry 3

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 138 shares

Expires 2031-02-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F2 · derivative.exercise_date: The restricted stock units vested in four equal annual installments beginning February 3, 2022.

SEC source: 0000950170-25-014816 · ownership.xml · nonDerivative · entry 2

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,495

SEC source: 0000950170-25-014816 · ownership.xml · nonDerivative · entry 1

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,536

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0000950170-25-011264 · ownership.xml · derivative · entry 1

Wyatt Christopher F. · CIK 0001673365 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,575

Underlying: Common Stock · 3,575 shares

Expires 2035-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.

SEC source: 0000950170-25-011262 · ownership.xml · derivative · entry 1

Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,469

Underlying: Common Stock · 4,469 shares

Expires 2035-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.

SEC source: 0000950170-25-011260 · ownership.xml · derivative · entry 4

McAlevey Michael R · CIK 0001907875 · EVP & Chief Legal & Admin Off.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,171

Underlying: Common Stock · 11,171 shares

Expires 2035-01-28

F2 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.

SEC source: 0000950170-25-011257 · ownership.xml · derivative · entry 1

Marks Mike A · CIK 0001961124 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,639

Underlying: Common Stock · 15,639 shares

Expires 2035-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.

SEC source: 0000950170-25-011254 · ownership.xml · derivative · entry 1

HAZEN SAMUEL N · CIK 0001216838 · Director · CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,620

Underlying: Common Stock · 74,620 shares

Expires 2035-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.

SEC source: 0000950170-25-011252 · ownership.xml · derivative · entry 1

Foster Jon M · CIK 0001513235 · EVP and COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,756

Underlying: Common Stock · 16,756 shares

Expires 2035-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.

SEC source: 0000950170-25-011251 · ownership.xml · derivative · entry 1

Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,171

Underlying: Common Stock · 11,171 shares

Expires 2035-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.

SEC source: 0000950170-25-011247 · ownership.xml · derivative · entry 1

Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,490

Underlying: Common Stock · 8,490 shares

Expires 2035-01-28

F1 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 28, 2026.